Antibodies That Inhibit TSLP Activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130225490A1
SERIAL NO

13887893

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNEX CORPORATIONTHOUSAND OAKS CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Armstrong, Allison P Seattle, US 7 71
Lyman, Stewart D Seattle, US 38 273
McKenna, Hilary J Seattle, US 14 156
Sims, John Ernest Seattle, US 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation